A mutant allele encoding DNA binding-deficient foxo1 differentially regulates hepatic glucose and lipid metabolism

Diabetes

Volumn 64, Issue 6, 2015, Pages 1951-1965

  Cook, Joshua R ^a   Matsumoto, Michihiro ^a,b   Banks, Alexander S ^a,c   Kitamura, Tadahiro ^a,d   Tsuchiya, Kyoichiro ^a,e   Accili, Domenico ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; LIPID; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; DNA; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DNA BINDING; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HETEROZYGOSITY; LIPID LIVER LEVEL; LIPOGENESIS; LIVER; LIVER CELL; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UPREGULATION; ALLELE; ANIMAL; CELL CULTURE; CELL LINE; GENETICS; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

ALLELES; ANIMALS; CELL LINE; CELLS, CULTURED; DNA; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HEPATOCYTES; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE; PROTEIN BINDING;

EID: 84938292410     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1506     Document Type: Article

References (48)

1. Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 2011;14:9-19.
2. Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 2011; 22:353-363.
3. Kim-Muller JY, Accili D. Cell biology. Selective insulin sensitizers. Science 2011;331:1529-1531.
4. Nakae J, Biggs WH 3rd, Kitamura T, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002;32:245-253.
5. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007;6:208-216.
6. Dong XC, Copps KD, Guo S, et al. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 2008;8:65-76.
7. Haeusler RA, Kaestner KH, Accili D. FoxOs function synergistically to promote glucose production. J Biol Chem 2010;285:35245-35248.
8. Nakae J, Kitamura T, Silver DL, Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 2001;108:1359-1367.
9. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006;116:2464-2472.
10. Tao R, Wei D, Gao H, Liu Y, DePinho RA, Dong XC. Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J Biol Chem 2011;286:14681-14690.
11. Wan M, Leavens KF, Saleh D, et al. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab 2011;14:516-527.
12. Haeusler RA, Pratt-Hyatt M, Welch CL, Klaassen CD, Accili D. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab 2012;15:65-74.
13. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002;2:81-91.
14. Kitamura T, Kitamura YI, Funahashi Y, et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest 2007;117: 2477-2485.
15. Fan W, Imamura T, Sonoda N, et al. FOXO1 transrepresses peroxisome proliferator- Activated receptor gamma transactivation, coordinating an insulininduced feed-forward response in adipocytes. J Biol Chem 2009;284:12188- 12197.
16. Turan S, Zehe C, Kuehle J, Qiao J, Bode J. Recombinase-mediated cassette exchange (RMCE) - A rapidly-expanding toolbox for targeted genomic modifications. Gene 2013;515:1-27.
17. Banks AS, Kim-Muller JY, Mastracci TL, et al. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylationdefective alleles in mice. Cell Metab 2011;14:587-597.
18. Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, Accili D. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 2013;19:1054-1060.
19. Brent MM, Anand R, Marmorstein R. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 2008;16: 1407-1416.
20. Tang ED, Nuñez G, Barr FG, Guan KL. Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 1999;274:16741-16746.
21. Zhao X, Gan L, Pan H, et al. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- And 14-3-3-dependent and -independent mechanisms. Biochem J 2004;378:839-849.
22. Hosaka T, Biggs WH 3rd, Tieu D, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 2004;101:2975-2980.
23. Pajvani UB, Shawber CJ, Samuel VT, et al. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 2011; 17:961-967.
24. Postic C, Dentin R, Denechaud PD, Girard J. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 2007;27:179-192.
25. Haeusler RA, Hartil K, Vaitheesvaran B, et al. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 2014;5:5190.
26. Ganjam GK, Dimova EY, Unterman TG, Kietzmann T. FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol. J Biol Chem 2009;284:30783-30797.
27. Hirota K, Sakamaki J, Ishida J, et al. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6- phosphatase genes in response to fasting and feeding. J Biol Chem 2008;283: 32432-32441.
28. Han S, Liang CP, Westerterp M, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 2009;119:1029-1041.
29. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 2000;6:77-86.
30. Gonzalez E, Flier E, Molle D, Accili D, McGraw TE. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci U S A 2011;108:10162-10167.
31. Hegarty BD, Bobard A, Hainault I, Ferré P, Bossard P, Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci U S A 2005;102: 791-796.
32. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003;423:550-555.
33. Lu M, Wan M, Leavens KF, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 2012;18:388-395.
34. Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development 1999;126:4603-4615.
35. Liu N, Barbosa AC, Chapman SL, et al. DNA binding-dependent and -independent functions of the Hand2 transcription factor during mouse embryogenesis. Development 2009;136:933-942.
36. Tomizawa M, Kumar A, Perrot V, Nakae J, Accili D, Rechler MM. Insulin inhibits the activation of transcription by a C- Terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription. J Biol Chem 2000;275:7289-7295.
37. Buteau J, Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic betacells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 2007;282:287-293.
38. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 2002;110:1839-1847.
39. Ramnanan CJ, Kraft G, Smith MS, et al. Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog. Diabetes 2013;62:74-84.
40. Bandsma RH, Wiegman CH, Herling AW, et al. Acute inhibition of glucose-6- phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. Diabetes 2001;50:2591-2597.
41. Dentin R, Pégorier JP, Benhamed F, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 2004;279:20314-20326.
42. Ferre T, Riu E, Franckhauser S, Agudo J, Bosch F. Long- Term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 2003;46:1662-1668.
43. Peter A, Stefan N, Cegan A, et al. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab 2011;96: E1126-E1130.
44. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non- Alcoholic fatty liver disease. Diabetes Metab 2003;29:478-485.
45. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351.
46. Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013;14:83-97.
47. Naïmi M, Gautier N, Chaussade C, Valverde AM, Accili D, Van Obberghen E. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinology 2007;148:2424-2434.
48. Xiong Y, Collins QF, An J, et al. p38 mitogen- Activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem 2007;282:4975-4982.